New Delhi: Drug major Sun Pharma on Wednesday announced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North American business.
Kal Sundaram, CEO of North American business, will move to India as CEO (India and emerging markets).
"Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma... Additionally, effective January 2017, Kal Sundaram, currently CEO, North America business will assume the position of CEO, India and emerging markets," the drug firm said in a statement.
While Gandhi will be based in the US, Sundaram will be based in Mumbai.
These appointments are subject to regulatory approvals.
New Delhi: Drug major Sun Pharma on Wednesday announced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North American business.
Kal Sundaram, CEO of North American business, will move to India as CEO (India and emerging markets).
"Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma... Additionally, effective January 2017, Kal Sundaram, currently CEO, North America business will assume the position of CEO, India and emerging markets," the drug firm said in a statement.
While Gandhi will be based in the US, Sundaram will be based in Mumbai.
These appointments are subject to regulatory approvals.
New Delhi: Drug major Sun Pharma on Wednesday announced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North American business.
Kal Sundaram, CEO of North American business, will move to India as CEO (India and emerging markets).
"Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma... Additionally, effective January 2017, Kal Sundaram, currently CEO, North America business will assume the position of CEO, India and emerging markets," the drug firm said in a statement.
While Gandhi will be based in the US, Sundaram will be based in Mumbai.
These appointments are subject to regulatory approvals.
Sign Up with Google
RECOMMENDED FOR YOU
POPULAR